This UK multicentre study provides evidence that 24-weekly Decapeptyl SR is both efficacious and well-tolerated for the management of CPP, with comparable outcomes to the standard 12-weekly regimen. This is the first comparative analysis to establish clinical equivalence between these two regimens, which is particularly important given the reduced frequency of clinical monitoring in the longer-acting preparation. Fewer injections may improve adherence and patient satisfaction, alongside potential cost savings.
Building similarity graph...
Analyzing shared references across papers
Loading...
Rachel Varughese
Lydia Lake
Bharathy Kothayan
University of Sheffield
Newcastle University
William Harvey Research Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Varughese et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69ada8a1bc08abd80d5bbca8 — DOI: https://doi.org/10.1210/clinem/dgag096